Review
Methods of Behavior Analysis in Neuroscience
2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009.
Affiliations
- PMID: 21204335
- Bookshelf ID: NBK5228
Item in Clipboard
Review
Methods of Behavior Analysis in Neuroscience
Excerpt
With contributions from more than 40 field specialists, Methods of Behavior Analysis in Neuroscience reflects six years of updates to its first bestselling edition and elucidates new behavioral approaches that are quickly becoming field standards.
This second edition features new material on the relevance of transgenic mouse models for Alzheimer's disease, behavioral methods for assessing the cognitive impairment associated with major psychotic disorders, the revival of the scopolamine reversal model for assessing the clinical relevance of new AD drugs, and new approaches to assessing the cognitive impairment in aged mice.
Copyright © 2009, Taylor & Francis Group, LLC.
Sections
- Dedication
- Series Preface
- Preface
- The Editor
- Contributors
- 1. Transgenic Mouse Models of Alzheimer’s Disease: Behavioral Testing and Considerations
- 2. Cued and Contextual Fear Conditioning for Rodents
- 3. Drug Discrimination
- 4. Conditioned Place Preference
- 5. Anxiety-Related Behaviors in Mice
- 6. Behavioral Assessment of Antidepressant Activity in Rodents
- 7. Assessing Attention in Rodents
- 8. The Behavioral Assessment of Sensorimotor Processes in the Mouse: Acoustic Startle, Sensory Gating, Locomotor Activity, Rotarod, and Beam Walking
- 9. Intravenous Drug Self-Administration in Nonhuman Primates
- 10. Contextually Induced Drug Seeking During Protracted Abstinence in Rats
- 11. Operant Analysis of Fronto-striatal Function in Rodents
- 12. Working Memory Delayed Response Tasks in Monkeys
- 13. Spatial Navigation (Water Maze) Tasks
- 14. Water Maze Tasks in Mice: Special Reference to Alzheimer’s Transgenic Mice
- 15. Behavioral Neuroscience of Zebrafish
-
16.
Caenorhabditis elegans Model for Initial Screening and Mechanistic Evaluation of Potential New Drugs for Aging and Alzheimer’s Disease - 17. The Revival of Scopolamine Reversal for the Assessment of Cognition-Enhancing Drugs
Similar articles
-
The Revival of Scopolamine Reversal for the Assessment of Cognition-Enhancing Drugs.In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 17. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor & Francis; 2009. Chapter 17. PMID: 21204339 Free Books & Documents. Review.
-
Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.J Neurol Sci. 2013 Dec 15;335(1-2):145-54. doi: 10.1016/j.jns.2013.09.018. Epub 2013 Sep 21. J Neurol Sci. 2013. PMID: 24095271
-
Use of artificial neural networks to determine cognitive impairment and therapeutic effectiveness in Alzheimer's transgenic mice.J Neurosci Methods. 2008 Jan 30;167(2):358-66. doi: 10.1016/j.jneumeth.2007.08.008. Epub 2007 Aug 19. J Neurosci Methods. 2008. PMID: 17904642
-
6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.Int J Risk Saf Med. 2015;27 Suppl 1:S69-71. doi: 10.3233/JRS-150694. Int J Risk Saf Med. 2015. PMID: 26639718
-
[Awareness disorders in Alzheimer's disease and in mild cognitive impairment].Encephale. 2014 Apr;40(2):180-7. doi: 10.1016/j.encep.2013.10.003. Epub 2014 Mar 11. Encephale. 2014. PMID: 24630532 Review. French.
Publication types
LinkOut - more resources
Full Text Sources
